Tempus AI Inc. (NASDAQ: TEM) Quarterly Earnings Preview and Financial Analysis

Core Insights - Tempus AI Inc. is a healthcare-focused AI company set to release its quarterly earnings on February 24, 2026, with an expected EPS of approximately -$0.04 and projected revenue of $362.6 million [1][6] Financial Performance - The company has a negative price-to-earnings (P/E) ratio of -49.16, yet its stock price has increased following an Outperform rating from Mizuho, which set a price target of $100 [2][6] - Tempus AI has a price-to-sales ratio of about 8.96, indicating investors are willing to pay nearly nine times the company's sales, while the enterprise value to sales ratio is approximately 9.58 [4] - The enterprise value to operating cash flow ratio is around -47.99, reflecting negative cash flow [4] - The company's debt-to-equity ratio is about 2.63, suggesting it has more than twice as much debt as equity, but it maintains a strong current ratio of approximately 3.28, indicating solid short-term financial stability [5] Product Development - Tempus AI announced a new HRD-RNA algorithm aimed at improving the detection of homologous recombination deficiency in tumors, which could enhance its market position [3][6]